135
Participants
Start Date
July 17, 2019
Primary Completion Date
November 29, 2021
Study Completion Date
November 29, 2021
Docetaxel in Parenteral Dosage Form
Treatment with IV docetaxel at 75 mg/m2 given as a one-hour infusion on day 1 every 21 days plus 5 mg oral prednisone twice daily
ModraDoc006/r
Treatment with twice daily once weekly (BIDW) ModraDoc006 (oral docetaxel) 10mg tablets in combination with ritonavir 100mg tablets
Orszagos Onkologiai Intezet (National Institute of Oncology), Budapest
Jasz-Nagykun-Szolnok Megyei - Hetenyi Geza Korhaz - Rendelointezet - Onkologiai Kozpont, Szolnok
Carolina Urologic Research Center, Myrtle Beach
Karmanos Cancer Institute, Detroit
Comprehensive Cancer Centers of Nevada, Las Vegas
Providence Cancer Institute, Portland
Nemocnice Liberec, Liberec
Urologicke oddeleni FTN, Prague
Universitätsmedizin Göttingen, Göttingen
Studienpraxis Urologie, Nürtingen
Universitätsklinikum Tübingen, Tübingen
Debreceni Egyetem Klinikai Központ, Debrecen
Petz Aladár Megyei Oktató Kórház, Győr
"Przychodnia Lekarska KOMED", Konin
Instytut Centrum Zdrowia Matki Polki, Lodz
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw
"Regional State Budgetary Healthcare Institution Altai regional oncology dispensary", Barnaul
"Limited Liability Company EVIMED", Chelyabinsk
"Regional State Budget Institution Krasnoyarsk Territorial Clinical Hospital n.a. A.I.Kryzhanovskogo", Krasnoyarsk
"Federal State Institution Russian Cancer Research Center named after N. N. Blokhin RAMS", Moscow
"CJSC Medical Center AVICENNA", Novosibirsk
"Federal state budget institution National medical research radiological center of the Ministry of healthcare of the Russian Federation, branch - A. Tsyb Medical Radiological Research Center", Obninsk
Clinical Oncological Dispensary of Omsk Region, Omsk
Leningrad Region Onco Dispensary, Saint Petersburg
"Limited Liability Company Klinika Andros [Andros Clinic]", Saint Petersburg
National medical research center of oncology n.a. N.N. Petrov, Saint Petersburg
Pavlov First Saint Petersburg State Medical University, Saint Petersburg
Sverdlovsk Regional Clinical Hospital No. 1, Yekaterinburg
Lead Sponsor
Modra Pharmaceuticals
INDUSTRY